Western Alliance Bancorp

WAL · NYSE

$75.30+$1.67 (+2.27%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $73.63

WAL analyst rating

BuyConsensus of 19 analysts over the last 12 months. 63% rate it a buy.

Strong buy0
Buy12
Hold6
Underperform1
Sell0

12-month price target · 16 analysts

Average $94.04 (+24.9% upside)

Low: $84.84
Now: $75.30
High: $101.85

Upgrades and downgrades

The latest rating actions, newest first

WAL analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Oct 9, 2026	Maintains	Outperform	$95.00 → $93.00	30%
Truist Securities	Oct 9, 2026	Maintains	Buy	$93.00 → $84.00	46%
Barclays	Oct 5, 2026	Maintains	Overweight	$88.00 → $93.00	54%
TD Cowen	Oct 5, 2026	Maintains	Hold	$90.00 → $85.00	47%
JP Morgan	Oct 1, 2026	Maintains	Neutral	$93.00 → $90.00	50%
Wells Fargo	Sep 30, 2026	Maintains	Equal-Weight	$90.00 → $84.00	62%
Citigroup	Sep 22, 2026	Maintains	Buy	$98.00 → $95.00	40%
Raymond James	Sep 22, 2026	Initiates	Outperform	$90.00	66%
Wells Fargo	Aug 10, 2026	Maintains	Equal-Weight	$79.00 → $90.00	62%
TD Cowen	Jul 27, 2026	Maintains	Hold	$89.00 → $90.00	47%

The case for and against

Updated Oct 14, 2026

Bull case

Western Alliance is supported by stable core credit metrics, with net charge-offs improving to 0.34% and classified and special mention balances both declining, even as the NPA uptick to $688M was tied to a previously disclosed life science lab/office CRE migration that management expects to work through. The company also showed resilient fee generation, as core fees of $183M beat consensus and mortgage servicing rebounded by $33M to $31.3M, helping offset margin pressure in GOS and a 2% rise in noninterest expense. A slower balance sheet growth outlook appears constructive because it should aid funding costs, preserve capital for share repurchases, and still allow strong profitability while revenue guidance outside mortgage remains largely unchanged.

Bear case

Western Alliance is facing a weaker fundamental setup because its earnings quality is being pressured by deliberate deposit contraction, higher noninterest expense, and a modestly weaker asset mix. Although 2Q26 NII rose to $807M and loans HFI increased $1.8B to $60.9B, EPS of $2.36 missed the $2.55 estimate as provisions and expenses rose, while period-end deposits fell $849M and NIM slipped to 3.53%. Asset quality also softened, with NPAs up 12% to $688M and the ACL only edging to 0.89%, reinforcing concerns that competitive funding pressure and sluggish loan demand could constrain profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.